Private Wealth Partners, LLC Oncocyte Corp Transaction History

Private Wealth Partners, LLC

  • $1.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$3.53 - $5.89 $529,500 - $883,500
-150,000 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$1.91 - $3.45 $133,700 - $241,500
70,000 Added 87.5%
150,000 $287,000
Q3 2019

Nov 12, 2019
BUY
$1.59 - $2.51 $127,200 - $200,799
80,000 New
80,000 $168,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $260M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Private Wealth Partners, LLC Portfolio

Follow Private Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email